Skip to content

Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians - Clinical Trial

To Critically Investigate and Evaluate Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians, Who May Have a Resultant Susceptibility to Hyperhomocysteinemia Related Diseases.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01661309
Enrollment
50
Registered
2012-08-09
Start date
2012-03-31
Completion date
2014-05-31
Last updated
2014-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin B12 Deficiency

Keywords

Hyperhomocysteinemia, Methylcobalamin, Cardiovascular disease, Plasma total homocysteine, Vegetarians

Brief summary

Vegetarians are known to be deficient in vitamin B12, due to a lack or absence of dietary animal produce, which can elevate homocysteine. There is strong evidence indicating that elevated plasma total homocysteine (tHcy) is a contributor to chronic conditions, such as primary cardiovascular disease (CVD). The study hypothesis is: There will be a significant decrease in plasma tHcy of vegetarians following the intervention by supplementary vitamin B12 (of the methylcobalamin type) and this will lead to a reduction of the risk of CVD.

Interventions

DIETARY_SUPPLEMENTInactive lozenge

Manufactured to mimic 1mg methylcobalamin lozenge

DIETARY_SUPPLEMENTMethylcobalamin

Aimed at reducing plasma tHcy.

Sponsors

University of West London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Having a plasma tHcy \>10 micromol/L * Not suffering from conditions as described in

Exclusion criteria

. * Vegetarian for at least one year. * Not participating in a weight reducing diet. * Not consuming regularly vitamin B12 supplements. * Give written consent to participate in clinical trial and be fluent in English language.

Design outcomes

Primary

MeasureTime frame
Reduction of plasma total homocysteine of vegetarians16 weeks per participant

Secondary

MeasureTime frame
Improvement in systolic and diastolic blood pressure16 weeks per participant

Other

MeasureTime frame
Improvement in body mass index16 weeks per participant

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026